Available early treatment protocols?

Mark Wauck at Meaning in History has useful information just in case you are exposed to COVID-19; his post concludes:

The article–What is causing COVID-19 deaths to spike in India?–is highly informative and contains multiple graphs that illustrate the author’s points in a useful way. Beyond that, however, the author points out another signal failure of our Covid response: the systemic failure to authorize a treatment regime for Covid. Indeed, we now know that the reason for this failure–this refusal–is closely linked to the push for vaxxing. Here is his conclusion:

This finding reinforces why an early treatment protocol is essential. However, my own doctor confirms there is no early treatment approved to treat COVID-19 in the U.S. (and probably most western countries) except quarantine with instructions to go to the hospital when symptoms worsen. This (perhaps criminal) omission is one more reason deaths got so high.  

A new anti-viral drug called Molupiravir is nearing completion of clinical trials.  It is intended as a five-day outpatient treatment similar to Tamiflu commonly prescribed to combat the effects of influenza. It would lack the unwarranted controversy surrounding the off-label use of HCQ making it ideal for an early treatment protocol.    

Until the CDC authorizes an early treatment protocol, we are on our own. However, there are several inexpensive, safe, common vitamins/drugs proven effective against COVID-19 that are available over the counter.  Examples include vitamin    D3,  Zinc, Glutathione, Quercetin, and even low-dose aspirin. There are others, and with some research you can be your own first responder. 

Full blog post is here.

# # #